Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2003
05/21/2003CN1109036C New process for prepn. of pharmacologically active substance
05/20/2003US6566541 Type 2 methionine aminopeptidase (MetAP2) inhibitors and uses thereof
05/20/2003US6566529 Dithienylthiophene derivatives attached to a 1,3,4-oxadiazole group and to either a carbazole group or a triphenylamine group, both attachments through vinylene groups; particularly for protection of human eyes and sensitive photodetectors
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/20/2003US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein
05/15/2003WO2003040288A2 Isotopically coded affinity markers 3
05/15/2003WO2003040127A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003WO2003000692A3 Oxytocin agonists
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003CA2466328A1 Isotopically coded affinity markers 3
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/14/2003EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof
05/14/2003EP1048651B1 Nitrogen-containing tetracyclic compounds
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562818 Irreversible inhibitors of tyrosine kinases
05/08/2003WO2003037904A1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
05/08/2003WO2003037903A1 Olanzapine dihydrate-ii a process for its preparation and use thereof
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003US20030088112 Comprising at least two moieties, each moiety being comprised of two or more thiophenes fused directly to each other; used to fabricate thin-film transistors (TFTs) or field-effect transistors (FETs).
05/08/2003US20030087935 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087881 Quinazoline derivatives used to treat cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465382A1 Indole compound and medicinal use thereof
05/08/2003CA2464306A1 Olanzapine dihydrate-ii a process for its preparation and use thereof
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0938491B1 Heterocyclic metallocenes and polymerization catalysts
05/07/2003EP0931074B1 Condensed 4,5,6,7-tetrahydrobenzo c]thiophenes as enhancer for cell differentiation induction factor action
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1107502C Prepn. method for medicinal compsn. contg. hydrogonated pyridine derivative as active components
05/06/2003US6559323 Degradation of hydrazone compound to diazo compound; catalysis with transition metal; reaction with sulfide
05/06/2003US6559177 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
05/06/2003US6559167 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under
05/06/2003US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
05/06/2003US6559145 Heterocycle carboxamides as antiviral agents
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1305305A1 Hyperpolarizable organic chromophores
05/02/2003EP1021448B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS
05/02/2003EP0672047B1 ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES
05/02/2003EP0662078B1 Reagents for peptide couplings
05/01/2003WO2003035653A1 Pyridothienopyrimidine compound and salt thereof
05/01/2003WO2003035652A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003034997A2 Modulators of phosphoinositide 3-kinase
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030080322 Reactive thienothiophenes
04/2003
04/29/2003US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
04/29/2003US6555555 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555528 Protease inhibitor
04/24/2003WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003WO2003033501A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003WO2003032999A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078276 Matrix metalloproteinase inhibitors
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078239 Ketone compounds and compositions for cholesterol management and related uses
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030077635 Dendrimer for use as diagnostic tools in chemical analysis
04/24/2003CA2463628A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003CA2462442A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/23/2003EP1304331A1 Iminobiotin derivative
04/23/2003EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/23/2003EP0981524B1 New intermediates and process for the preparation thereof
04/23/2003EP0915846B1 2- and 2,5-substituted phenylketoenols
04/23/2003EP0885391B1 Method of detection of influenza virus and compounds for use therein
04/23/2003EP0854723B1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
04/23/2003EP0656005B1 Biotinylated chemiluminescent label, conjugates, assays, assay kits
04/23/2003CN1106196C Application of Odenping medicine for treating migraine pain
04/22/2003US6552017 Substituted heterocycle fused gamma-carbolines
04/22/2003US6551794 Includes a protectant selected from a specified zwitterionic amino acid(s), trehalose, glycerol and ammonium sulphate, a buffer, and water soluble bulking agents; making fibrin; stabilized thrombin-like enzyme; sterility
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/17/2003WO2002092564A3 Synthesis of cyclopentadiene derivatives
04/17/2003US20030073733 Pharmaceutically active compounds and methods of use
04/17/2003US20030073706 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/16/2003EP1301517A1 Thienopyrrolidinones
04/16/2003EP1301516A1 Modulators of protein tyrosine phosphatases (ptpases)
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 214